Synchronous nodal metastatic risk in screening detected and endoscopically removed pT1 colorectal cancers

Torre, 2016, Global Cancer incidence and mortality rates and trends--An update, Cancer Epidemiol. Biomarkers Prev., 25, 16, 10.1158/1055-9965.EPI-15-0578 von Karsa, 2013, European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication, Endoscopy, 45, 51 Brierley Je, Gospodarowicz MKe, Wittekind Ce. TNM classification of malignant tumours. Cappellesso, 2017, Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis, Hum. Pathol., 65, 62, 10.1016/j.humpath.2017.04.013 Hohenberger, 2009, Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome, Colorectal Dis., 11, 354, 10.1111/j.1463-1318.2008.01735.x Steele, 2012, Cancer IAfRo. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Management of lesions detected in colorectal cancer screening, Endoscopy, 44, SE140 Watanabe, 2012, Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer, Int. J. Clin. Oncol., 17, 1, 10.1007/s10147-011-0315-2 Bosch, 2013, Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions, Endoscopy, 45, 827, 10.1055/s-0033-1344238 Kawachi, 2015, A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study, Mod. Pathol., 28, 872, 10.1038/modpathol.2015.36 Toh, 2015, Area of submucosal invasion and width of invasion predicts lymph node metastasis in pT1 colorectal cancers, Dis. Colon Rectum, 58, 393, 10.1097/DCR.0000000000000315 Ueno, 2002, Tumour’ budding’ as an index to estimate the potential of aggressiveness in rectal cancer, Histopathology, 40, 127, 10.1046/j.1365-2559.2002.01324.x Koelzer, 2016, Tumor budding in colorectal cancer--ready for diagnostic practice?, Hum. Pathol., 47, 4, 10.1016/j.humpath.2015.08.007 Cappellesso, 2015, The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma, Histopathology, 67, 491, 10.1111/his.12668 Galon, 2006, Type, density, and location of immune cells within human colorectal tumors predict clinical outcome, Science, 313, 1960, 10.1126/science.1129139 Pagès, 2005, Effector memory T cells, early metastasis, and survival in colorectal cancer, N. Engl. J. Med., 353, 2654, 10.1056/NEJMoa051424 Mlecnik, 2011, Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction, J. Clin. Oncol., 29, 610, 10.1200/JCO.2010.30.5425 Pagès, 2009, In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer, J. Clin. Oncol., 27, 5944, 10.1200/JCO.2008.19.6147 Nosho, 2010, Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review, J. Pathol., 222, 350, 10.1002/path.2774 Samowitz, 2001, Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level, Cancer Epidemiol. Biomarkers Prev., 10, 917 Benatti, 2005, Microsatellite instability and colorectal cancer prognosis, Clin. Cancer Res., 11, 8332, 10.1158/1078-0432.CCR-05-1030 Gong, 2018, Mismatch repair-deficient status associates with favorable prognosis of Eastern Chinese population with sporadic colorectal cancer, Oncol. Lett., 15, 7007 Malesci, 2007, Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer, Clin. Cancer Res., 13, 3831, 10.1158/1078-0432.CCR-07-0366 Rosty, 2014, Should the grading of colorectal adenocarcinoma include microsatellite instability status?, Hum. Pathol., 45, 2077, 10.1016/j.humpath.2014.06.020 Atkin, 2012, European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Colonoscopic surveillance following adenoma removal, Endoscopy, 44, SE151 Primrose, 2014, Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial, JAMA, 311, 263, 10.1001/jama.2013.285718 Pita-Fernández, 2015, Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis, Ann. Oncol., 26, 644, 10.1093/annonc/mdu543 Altman, 2012, Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration, PLoS Med., 9, 10.1371/journal.pmed.1001216 Bosman, 2010 Vieth, 2012, Cancer IAfRo. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Annotations of colorectal lesions, Endoscopy, 44, SE131 Lugli, 2017, Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016, Mod. Pathol., 30, 1299, 10.1038/modpathol.2017.46 Cappellesso, 2015, HER2 status in gastroesophageal cancer: a tissue microarray study of 1040 cases, Hum. Pathol., 46, 665, 10.1016/j.humpath.2015.02.007 Shia, 2013, Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry, Fam. Cancer, 12, 241, 10.1007/s10689-013-9612-4 Remo, 2016, Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal, Pathologica, 108, 104 Compton, 2000, Prognostic factors in colorectal cancer. College of American pathologists consensus statement 1999, Arch. Pathol. Lab. Med., 124, 979, 10.5858/2000-124-0979-PFICC Bianco, 2015, Practice parameters for early colon cancer management: italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines, Tech. Coloproctol., 19, 577, 10.1007/s10151-015-1361-y Cooper, 1995, Endoscopically removed malignant colorectal polyps: clinicopathologic correlations, Gastroenterology, 108, 1657, 10.1016/0016-5085(95)90126-4 Gill, 2013, Management and short-term outcome of malignant colorectal polyps in the north of England(1), Colorectal Dis., 15, 169, 10.1111/j.1463-1318.2012.03130.x Schmidt, 2018, Colonoscopic full-thickness resection using an over-the-scope device: a prospective multicentre study in various indications, Gut, 67, 1280, 10.1136/gutjnl-2016-313677 Vitali, 2018, Endoscopic full-thickness resection with an over-the-scope clip device (FTRD) in the colorectum: results from a university tertiary referral center, Endosc. Int. Open, 6, E98, 10.1055/s-0043-124079 Smith, 2011, Lymphatic vessel distribution in the mucosa and submucosa and potential implications for T1 colorectal tumors, Dis. Colon Rectum, 54, 35, 10.1007/DCR.0b013e3181fb0e7a Suzuki, 2003, Risk of lymph node and distant metastases in patients with early invasive colorectal cancer classified as Haggitt’s level 4 invasion: image analysis of submucosal layer invasion, Dis. Colon Rectum, 46, 203, 10.1007/s10350-004-6525-1 Dolcetti, 1999, High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability, Am. J. Pathol., 154, 1805, 10.1016/S0002-9440(10)65436-3 Scarpa, 2015, Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance, Oncotarget, 6, 43472, 10.18632/oncotarget.6179 Dunn, 2006, Interferons, immunity and cancer immunoediting, Nat. Rev. Immunol., 6, 836, 10.1038/nri1961 Chalmers, 2017, Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden, Genome Med., 9, 34, 10.1186/s13073-017-0424-2 Mazzolini, 2007, Immunotherapy and immunoescape in colorectal cancer, World J. Gastroenterol., 13, 5822, 10.3748/wjg.v13.i44.5822 Tosolini, 2011, Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer, Cancer Res., 71, 1263, 10.1158/0008-5472.CAN-10-2907 Yoshida, 2016, A high RORγT/CD3 ratio is a strong prognostic factor for postoperative survival in advanced colorectal Cancer: analysis of helper t cell lymphocytes (Th1, Th2, Th17 and regulatory t cells), Ann. Surg. Oncol., 23, 919, 10.1245/s10434-015-4923-3